Matthew R. Olson

2.6k total citations
40 papers, 2.0k citations indexed

About

Matthew R. Olson is a scholar working on Immunology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew R. Olson has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 9 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew R. Olson's work include Immune Cell Function and Interaction (31 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (16 papers). Matthew R. Olson is often cited by papers focused on Immune Cell Function and Interaction (31 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (16 papers). Matthew R. Olson collaborates with scholars based in United States, Australia and Czechia. Matthew R. Olson's co-authors include Mark H. Kaplan, Steven M. Varga, Matthew M. Hufford, Sungtae Park, Elaine M. Castilow, Stephen T. Turner, Stacey M. Hartwig, Rukhsana Jabeen, Brendan E. Russ and Alice E. Denton and has published in prestigious journals such as Journal of Clinical Investigation, Immunity and Nature reviews. Immunology.

In The Last Decade

Matthew R. Olson

39 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew R. Olson United States 22 1.2k 543 478 294 205 40 2.0k
Anna Cerny United States 25 1.0k 0.9× 606 1.1× 518 1.1× 179 0.6× 304 1.5× 29 1.9k
Damian M. Carragher United States 13 1.1k 0.9× 438 0.8× 246 0.5× 280 1.0× 139 0.7× 18 1.6k
Nigel D. L. Savage Netherlands 17 1.2k 1.0× 430 0.8× 493 1.0× 295 1.0× 519 2.5× 23 2.1k
Paula S. Norris United States 20 1.1k 0.9× 510 0.9× 528 1.1× 493 1.7× 134 0.7× 30 2.0k
Nicola Borthwick United Kingdom 25 2.0k 1.7× 544 1.0× 506 1.1× 425 1.4× 301 1.5× 58 2.8k
Navjiwan Mann United States 10 1.6k 1.4× 446 0.8× 506 1.1× 194 0.7× 125 0.6× 11 2.4k
Olena Kamenyeva United States 20 813 0.7× 329 0.6× 815 1.7× 257 0.9× 322 1.6× 44 2.1k
Ralph F. Hopkins United States 16 660 0.6× 397 0.7× 570 1.2× 493 1.7× 227 1.1× 22 1.8k
Christine Bourgeois France 28 2.0k 1.7× 358 0.7× 346 0.7× 494 1.7× 336 1.6× 59 2.9k

Countries citing papers authored by Matthew R. Olson

Since Specialization
Citations

This map shows the geographic impact of Matthew R. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Olson more than expected).

Fields of papers citing papers by Matthew R. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Olson. The network helps show where Matthew R. Olson may publish in the future.

Co-authorship network of co-authors of Matthew R. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Olson. A scholar is included among the top collaborators of Matthew R. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Olson. Matthew R. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Sungtae, et al.. (2024). GRANZYME A-PRODUCING CD4 T CELLS ARE DRIVERS OF IMMUNE CHECKPOINT BLOCKADE-INDUCED COLITIS. Inflammatory Bowel Diseases. 30(Supplement_1). S59–S60.
2.
Yan, Bingyu, et al.. (2022). IL-1β promotes IL-9-producing Th cell differentiation in IL-2-limiting conditions through the inhibition of BCL6. Frontiers in Immunology. 13. 1032618–1032618. 9 indexed citations
3.
Park, Sungtae, et al.. (2021). Granzyme-Producing CD4 T Cells in Cancer and Autoimmune Disease. ImmunoHorizons. 5(12). 909–917. 15 indexed citations
4.
Park, Sungtae, et al.. (2018). Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. PMC. 3 indexed citations
5.
Park, Sungtae, et al.. (2018). Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. Frontiers in Immunology. 9. 1212–1212. 198 indexed citations
6.
Cheung, Ka Lung, Fan Zhang, Anbalagan Jaganathan, et al.. (2017). Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation. Molecular Cell. 65(6). 1068–1080.e5. 101 indexed citations
7.
Russ, Brendan E., Moshe Olshansky, Jasmine Li, et al.. (2017). Regulation of H3K4me3 at Transcriptional Enhancers Characterizes Acquisition of Virus-Specific CD8+ T Cell-Lineage-Specific Function. Cell Reports. 21(12). 3624–3636. 42 indexed citations
8.
Olson, Matthew R., et al.. (2016). STAT3 Impairs STAT5 Activation in the Development of IL-9–Secreting T Cells. The Journal of Immunology. 196(8). 3297–3304. 31 indexed citations
9.
Koh, Byunghee, Matthew M. Hufford, Duy Pham, et al.. (2016). The ETS Family Transcription Factors Etv5 and PU.1 Function in Parallel To Promote Th9 Cell Development. The Journal of Immunology. 197(6). 2465–2472. 38 indexed citations
10.
Kaplan, Mark H., Matthew M. Hufford, & Matthew R. Olson. (2015). The development and in vivo function of T helper 9 cells. PMC. 1 indexed citations
11.
Kaplan, Mark H., Matthew M. Hufford, & Matthew R. Olson. (2015). The development and in vivo function of T helper 9 cells. Nature reviews. Immunology. 15(5). 295–307. 272 indexed citations
12.
Bird, Nicola L., Matthew R. Olson, Aeron C. Hurt, et al.. (2015). Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses. PLoS ONE. 10(6). e0129768–e0129768. 24 indexed citations
13.
Russ, Brendan E., Heather S. Smallwood, Jasmine Li, et al.. (2014). Distinct Epigenetic Signatures Delineate Transcriptional Programs during Virus-Specific CD8+ T Cell Differentiation. Immunity. 41(5). 853–865. 166 indexed citations
14.
Russ, Brendan E., Heather S. Smallwood, Jasmine Li, et al.. (2014). Distinct Epigenetic Signatures Delineate Transcriptional Programs during Virus-Specific CD8+ T Cell Differentiation. Immunity. 41(6). 1064–1064. 2 indexed citations
15.
Russ, Brendan E., et al.. (2012). Defining the molecular blueprint that drives CD8+ T cell differentiation in response to infection. Frontiers in Immunology. 3. 371–371. 14 indexed citations
16.
Olson, Matthew R., et al.. (2012). The Initial Draining Lymph Node Primes the Bulk of the CD8 T Cell Response and Influences Memory T Cell Trafficking after a Systemic Viral Infection. PLoS Pathogens. 8(12). e1003054–e1003054. 30 indexed citations
17.
Croom, Hayley A., Alice E. Denton, Sophie Valkenburg, et al.. (2010). Memory precursor phenotype of CD8+ T cells reflects early antigenic experience rather than memory numbers in a model of localized acute influenza infection. European Journal of Immunology. 41(3). 682–693. 16 indexed citations
18.
Olson, Matthew R., Brendan E. Russ, Peter C. Doherty, & Stephen T. Turner. (2010). The role of epigenetics in the acquisition and maintenance of effector function in virus‐specific CD8 T cells. IUBMB Life. 62(7). 519–526. 7 indexed citations
19.
Olson, Matthew R., Stacey M. Hartwig, & Steven M. Varga. (2008). The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia. The Journal of Immunology. 181(11). 7958–7968. 56 indexed citations
20.
Olson, Matthew R. & Steven M. Varga. (2007). CD8 T Cells Inhibit Respiratory Syncytial Virus (RSV) Vaccine-Enhanced Disease. The Journal of Immunology. 179(8). 5415–5424. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Cerny Breakdown of academic impact, for papers by Damian M. Carragher Breakdown of academic impact, for papers by Nigel D. L. Savage Breakdown of academic impact, for papers by Paula S. Norris Breakdown of academic impact, for papers by Nicola Borthwick Breakdown of academic impact, for papers by Navjiwan Mann Breakdown of academic impact, for papers by Olena Kamenyeva Breakdown of academic impact, for papers by Ralph F. Hopkins Breakdown of academic impact, for papers by Christine Bourgeois
Rankless by CCL
2026